At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we believe transparency of clinical trial data advances science and medicine and is in the best interest of the patients who use our pharmaceutical products and providers who prescribe them.
Janssen agreement on sharing of clinical trial data with Yale School of Medicine
Janssen Research and Development, LLC, has entered into an agreement with Yale School of Medicine’s Open Data Access (YODA) Project to extend its commitment to sharing clinical trials data to enhance public health and advance science and medicine. Under the agreement, YODA will serve as an independent body to review requests from investigators and physicians seeking access to anonymised clinical trials data from Janssen and make final decisions on data sharing. This is the first time any company has collaborated with a completely independent third party to review and make decisions regarding every request for clinical data. In addition to sharing data from Janssen’s pharmaceutical product clinical trials through the agreement with YODA, Johnson & Johnson is also committed to sharing data from clinical trials of its medical device and consumer products.
We support the overall principles of greater clinical trial data transparency, including registration and disclosure of clinical trial results in external registries, publication of results in peer reviewed journals, and sharing of Clinical Study Reports (CSRs), as outlined below.
Registration and Disclosure of Clinical Trial Results
Publication of Clinical Trials Results in Peer-Reviewed Journals
Sharing of Clinical Study Reports (CSRs)
For more information about our clinical trials please visit :
ClinicalTrials.gov provides patients, their family members, and the public with easy and free access to information on clinical studies for a wide range of diseases and conditions. The Web site is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). Information on ClinicalTrials.gov is provided and updated by the sponsor or principal investigator of the clinical study.
© Janssen Pharmaceutica N.V. 2014
This site is published by Janssen Pharmaceutica N.V., which is solely responsible for its content.
This site is intended for the use of our visitors in Europe, the Middle East and Africa - Last updated on 29 March 2015.
The Press Corner section is intented to provide resources for media professionals only. It is not inteded for use by healthcare professionals, patients or the general public.
To access, please confirm that you are an accredited menber of the press.